OOIR: Observatory of International Research

Papers

(The H4-Index of International Journal of Drug Policy is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Tackling the overdose crisis: The role of safe supply	123
Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019”	98
Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada	86
Safer opioid distribution in response to the COVID-19 pandemic	74
COVID-19 and the health of people who use drugs: What is and what could be?	70
Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update	70
Syringe services program (SSP) operational changes during the COVID-19 global outbreak	69
An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods	66
Buprenorphine dispensing in an epicenter of the U.S. opioid epidemic: A case study of the rural risk environment in Appalachian Kentucky	64
A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System	64
Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose?	63
The impact of COVID-19 restrictions on needle and syringe programme provision and coverage in England	58
Continuing increased access to buprenorphine in the United States via telemedicine after COVID-19	56
“You are not clean until you're not on anything”: Perceptions of medication-assisted treatment in rural Appalachia	56
Making “bad trips” good: How users of psychedelics narratively transform challenging trips into valuable experiences	54
Communicating THC levels and ‘dose’ to consumers: Implications for product labelling and packaging of cannabis products in regulated markets	50
Access to cannabidiol without a prescription: A cross-country comparison and analysis	49
I don't even want to go to the doctor when I get sick now: Healthcare experiences and discrimination reported by people who use drugs, Arizona 2019	47
A rapid review of the impacts of “Big Events ” on risks, harms, and service delivery among people who use drugs: Implications for responding to COVID-19	46
Changes in characteristics of drug overdose death trends during the COVID-19 pandemic	46
Multi-level drivers of tobacco use and purchasing behaviors during COVID-19 “lockdown”: A qualitative study in the United States	45
From the clinic to the street: the changing role of benzodiazepines in the Scottish overdose epidemic	44
COVID-19 - Enacting a ‘new normal’ for people who use drugs	44
Drugs as technologies of the self: Enhancement and transformation in LGBTQ cultures	43
Doing ontopolitically-oriented research: Synthesising concepts from the ontological turn for alcohol and other drug research and other social sciences	43

Care during COVID-19: Drug use, harm reduction, and intimacy during a global pandemic	43
Selectivity and sensitivity of urine fentanyl test strips to detect fentanyl analogues in illicit drugs	43
Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis	43
A narrative systematic review of sexualised drug use and sexual health outcomes among LGBT people	42
Destabilising the ‘problem’ of chemsex: Diversity in settings, relations and practices revealed in Australian gay and bisexual men's crystal methamphetamine use	42
Intersectional structural vulnerability to abusive policing among people who inject drugs: A mixed methods assessment in California's central valley	40
Agency in the fentanyl era: Exploring the utility of fentanyl test strips in an opaque drug market	40
Pathways between COVID-19 public health responses and increasing overdose risks: A rapid review and conceptual framework	40
“That's why people don't call 911”: Ending routine police attendance at drug overdoses	40
Intentions, actions and outcomes: A follow up survey on harm reduction practices after using an English festival drug checking service	38
Evaluation of fentanyl test strip distribution in two Mid-Atlantic syringe services programs	38
Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): A qualitative study of experiences of COVID-19 among people who inject drugs	38
Addressing co-occurring public health emergencies: The importance of naloxone distribution in the era of COVID-19	37
“How will I get my next week's script?” Reactions of Reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic	37